Patient ID
|
Sample ID
|
Sample type
|
Number DTCs analyzed/total DTCs collected*
|
Number TCs analyzed/total TCs collected*
|
Number DTCs or TCs with PIK3CAexon 9 mutation
|
Number DTCs or TCs with PIK3CAexon 20 mutation
|
---|
12
|
12-11 (T)
|
L2 bone metastasis (spine)
|
-
|
8/10
|
8
|
0
|
12
|
12-12 (T)
|
Bone marrow
|
24/75
|
-
|
24
|
0
|
13
|
13-1 (T)
|
Primary tumor
|
-
|
5/10
|
0
|
0
|
14
|
14-1 (T)
|
Primary tumor (core bx)
|
-
|
5/10
|
1
|
0
|
15
|
15-1 (T)
|
LN metastasis
|
-
|
5/10
|
3
|
0
|
16
|
16-1 (T)
|
Primary tumor
|
-
|
5/10
|
0
|
0
|
17
|
17-1 (T)
|
Primary tumor
|
-
|
5/10
|
0
|
0
|
TOTALS
|
6 patients
|
7 samples
|
-
|
24/75
|
33/60
|
36
|
0
|
-
DTCs disseminated tumor cells from bone marrow, TCs tumor cells from primary or metastatic tumors;
-
LN lymph node, L2 second lumbar vertebra, Bx biopsy, ND not determined.
- *DTCs or TCs not analyzed for mutations were used for immunostaining or other molecular assays.